RGNX Return on Tangible Equity | REGENXBIO Inc.

REGENXBIO Inc. (RGNX) Return on Tangible Equity

2026-06-30: Return Tang Equity -273.72%.
2026-03-31: Return Tang Equity -1375.64%.
2025-12-31: Return Tang Equity -188.72%.
2025-09-30: Return Tang Equity -110.20%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-273.72%
2026-03-31	-1375.64%
2025-12-31	-188.72%
2025-09-30	-110.20%
2025-06-30	-82.17%
2025-03-31	-57.51%
2024-12-31	-87.46%
2024-09-30	-79.23%
2024-06-30	-69.22%
2024-03-31	-66.59%
2023-12-31	-84.52%
2023-09-30	-71.75%
2023-06-30	-67.55%
2023-03-31	-58.11%
2022-12-31	-54.31%
2022-09-30	13.06%
2022-06-30	14.39%
2022-03-31	14.68%
2021-12-31	16.73%
2021-09-30	-46.04%
2021-06-30	-28.63%
2021-03-31	-21.88%
2020-12-31	-29.45%
2020-09-30	-22.01%
2020-06-30	-33.89%
2020-03-31	-24.41%
2019-12-31	-21.04%
2019-09-30	-13.66%
2019-06-30	-9.82%
2019-03-31	-7.50%
2018-12-31	19.64%
2018-09-30	16.12%
2018-06-30	24.63%
2018-03-31	17.73%
2017-12-31	-39.98%
2017-09-30	-39.44%
2017-06-30	-35.06%
2017-03-31	-34.85%
2016-12-31	-38.93%
2016-09-30	-26.93%
2016-06-30	-19.22%
2016-03-31	-14.17%
2015-12-31	-10.52%
2015-09-30	-9.00%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-188.72%
2024-12-31	-87.46%
2023-12-31	-84.52%
2022-12-31	-54.31%
2021-12-31	16.73%
2020-12-31	-29.45%
2019-12-31	-21.04%
2018-12-31	19.64%
2017-12-31	-39.98%
2016-12-31	-38.93%
2015-12-31	-10.52%
2014-12-31	21.89%
2013-12-31	38.70%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Entera Bio Ltd. (ENTX)		$0.485B
Tectonic Therapeutic, Inc. (TECX)	United States	$0.469B	-7.68
Autolus Therapeutics plc (AUTL)		$0.506B	-1.52
Eikon Therapeutics, Inc. (EIKN)	United States	$0.446B
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Prime Medicine, Inc. (PRME)	United States	$0.557B	-3.54
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Surrozen, Inc./DE (SRZN)	United States	$0.395B